DaVita (DVA) Financials: History & Chart

DaVita Inc. (DVA)DVADaVita Inc.

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO

78,000 employees

www.davita.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Javier J. Rodriguez

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	13.84B	3.42B	3.62B	3.42B	3.38B	3.22B	3.29B	3.26B	3.19B
Cost of Goods Sold	9.53B	2.34B	2.60B	2.33B	2.26B	2.24B	2.23B	2.15B	2.14B
Gross Profit	4.30B	1.07B	1.02B	1.09B	1.12B	983.87M	1.07B	1.11B	1.04B
Gross Profit Margin	31.1%	31.4%	28.3%	31.8%	33.1%	30.5%	32.5%	34.1%	32.8%
Total Operating Expenses	2.23B	591.40M	472.36M	581.70M	580.14M	544.93M	503.95M	576.84M	538.02M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	1.72B	421.91M	472.36M	414.37M	412.81M	374.09M	414.48M	393.53M	367.85M
Operating Income (EBIT)	2.08B	481.89M	551.21M	505.77M	537.84M	438.94M	565.36M	534.88M	506.40M
Operating Margin	15.0%	14.1%	15.2%	14.8%	15.9%	13.6%	17.2%	16.4%	15.9%
Income Before Tax (EBT)	1.40B	341.23M	382.76M	308.80M	368.93M	286.33M	413.73M	373.43M	371.44M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	559.75M	145.13M	118.00M	150.56M	146.06M	135.06M	138.72M	134.58M	97.75M
Other Income/Expense	-674.98M	-140.66M	-168.45M	-196.96M	-168.91M	-152.60M	-151.63M	-161.44M	-134.96M
Net Income	781.42M	197.53M	234.22M	150.33M	199.34M	162.92M	259.33M	214.69M	222.68M
Income Tax Expense	305.19M	66.20M	76.73M	68.55M	93.71M	54.12M	64.49M	77.67M	71.69M
Net Profit Margin	5.6%	5.8%	6.5%	4.4%	5.9%	5.1%	7.9%	6.6%	7.0%
EBITDA	2.79B	659.72M	737.91M	683.26M	712.54M	615.39M	739.46M	721.89M	682.06M
EBITDA Margin	20.2%	19.3%	20.4%	20.0%	21.1%	19.1%	22.4%	22.1%	21.4%
Depreciation & Amortization	716.73M	177.83M	186.70M	177.49M	174.70M	176.45M	174.10M	187.01M	175.66M
EPS Basic	10.15	2.93	2.51	2.09	2.62	2.05	3.18	2.56	2.56
EPS Diluted	9.94	2.87	2.45	2.04	2.58	2.00	3.09	2.50	2.50
Shares Outstanding	67.39M	67.39M	86.10M	72.08M	75.94M	79.37M	81.62M	83.72M	86.90M
Diluted Shares Outstanding	68.88M	68.88M	88.10M	73.77M	77.36M	81.28M	83.85M	85.80M	88.95M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	13.64B	12.82B	12.14B	11.61B	11.62B	11.55B	11.39B	11.40B
Cost of Goods Sold	9.96B	8.60B	8.32B	8.21B	7.97B	7.99B	7.91B	8.20B
Gross Profit	3.68B	4.22B	3.82B	3.40B	3.65B	3.56B	3.47B	3.21B
Gross Profit Margin	27.0%	32.9%	31.5%	29.3%	31.4%	30.8%	30.5%	28.1%
Total Operating Expenses	1.67B	2.13B	2.22B	2.06B	1.85B	1.87B	1.83B	1.68B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	1.67B	1.54B	1.47B	1.36B	1.20B	1.25B	1.10B	1.14B
Operating Income (EBIT)	2.01B	2.09B	1.60B	1.34B	1.80B	1.69B	1.64B	1.53B
Operating Margin	14.7%	16.3%	13.2%	11.5%	15.5%	14.7%	14.4%	13.4%
Income Before Tax (EBT)	1.35B	1.53B	1.18B	966.28M	1.52B	1.32B	1.20B	1.05B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	549.67M	470.47M	398.55M	357.02M	285.25M	304.11M	443.82M	487.44M
Other Income/Expense	-663.79M	-560.09M	-425.69M	-372.78M	-278.88M	-376.37M	-447.88M	-477.35M
Net Income	746.80M	936.34M	691.53M	560.40M	978.45M	773.64M	810.98M	159.39M
Income Tax Expense	293.11M	279.66M	220.12M	198.09M	306.73M	313.93M	279.63M	258.40M
Net Profit Margin	5.5%	7.3%	5.7%	4.8%	8.4%	6.7%	7.1%	1.4%
EBITDA	2.73B	2.81B	2.35B	2.07B	2.48B	2.33B	2.26B	2.12B
EBITDA Margin	20.0%	22.0%	19.3%	17.8%	21.3%	20.1%	19.8%	18.6%
Depreciation & Amortization	715.35M	723.86M	745.44M	732.60M	680.62M	630.43M	615.15M	591.03M
EPS Basic	9.72	11.02	7.62	5.88	9.30	6.54	5.29	4.63
EPS Diluted	9.51	10.73	7.42	5.71	8.90	6.39	5.27	4.58
Shares Outstanding	86.10M	84.99M	90.79M	92.99M	105.23M	119.80M	153.18M	170.79M
Diluted Shares Outstanding	88.10M	87.27M	93.18M	95.83M	109.95M	122.62M	153.81M	172.36M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.